Show Notes
Hormones in the intestine have proven to play an important role in managing type 2 diabetes, as well as regulating growth and function of the beta cell and the intestinal tract. But what does all of that mean for those living with the condition?
On this episode Dr. Patricia Brubaker discusses her work with glucagon-like peptides. Dr. Brubaker is a Professor in the department of Physiology at the University of Toronto and a Canada Research Chair in Vascular and Metabolic Biology.
She is also the 2020 winner of the Diabetes Canada Lifetime Achievement Award for her outstanding contribution to diabetes research.
More from Diabetes Canada Podcast
Diabetic ketoacidosis, or DKA, is one of the most feared complications of type 1 diabetes. That’s why researchers are looking for new and innovative ways to increase awareness of what DKA is and how it can be prevented.
How can we change the conversation about diabetes? For Diabetes Awareness Month, that’s a question Diabetes Canada is tackling head on.
How can we change the conversation about diabetes? For Diabetes Awareness Month, that’s a question Diabetes Canada is tackling head on.
Many people are at risk for both diabetes and heart attacks. Millions of people take statin drugs to lower bad cholesterol and reduce the risk of heart attacks. But could these drugs also increase the risk for type 2 diabetes?
As technology in type 1 diabetes becomes more advanced, we are starting to see an increase in personalized therapies. Whether someone is using hybrid closed loop or multiple daily injections, there are options being studied to make living with diabetes easier to manage.